ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 750501 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 750501; 2) Community: the network communities that were significantly associated with the response to NSC 750501; 3) Molecule: the relationships between components within communities and NSC 750501; 4) MDR: the compounds that were significantly associated with the NSC 750501.

NSC Compound Enrichment Correlation
NSC 379507 Null 0.00782274809018299 -0.22444192
NSC 672170 2-Thiophenecarboxaldehyde, 5-[5-[5-(hydroxymethyl)- 2-thienyl]-2-furanyl]- 0.00782274809018299 -0.10661411
NSC 149501 Bleomycinamide, N(1)-[3-[(4-aminobutyl)amino]propyl]-, sulfate (salt) 0.00783051864107159 -0.10233739
NSC 606869 Clofarabine 0.00783051864107159 -0.11537319
NSC 684910 2,6-Pyrimidinediamine, 4-chloro-5-[(4-chlorophenyl)azo]- N(6)-[[1-(hydroxymethyl)-3-(phenylmethoxy)cyclobutyl] methyl]-, (Isomer B)-, stereoisomer of NSC-684909 0.00783051864107159 -0.20561557
NSC 698095 Null 0.00783051864107159 -0.19189294
NSC 759263 Topotecan hydrochloride (USAN) 0.0078305186410717 0.096133585
NSC 240529 2,5-Cyclohexadien-1-one, 4-[[4-[bis(2-chloroethyl)amino]phenyl]imino]-2,6-dimethyl- 0.00863223795880985 -0.10453106
NSC 338048 Isoquinolinium, 2-(2,4-dinitrophenyl)-, chloride 0.00863223795880985 -0.063192744
NSC 357704 Cyanomorpholinodoxorubicin 0.00863223795880985 -0.012984301
Total:40  Current:6    [First] [Prev] [Next] [Last]